111 related articles for article (PubMed ID: 11507947)
1. Perspective. Senior drug use unique, needs management, analysts say.
Med Health; 2001 Aug; 55(30):7-8. PubMed ID: 11507947
[No Abstract] [Full Text] [Related]
2. The effect of a copay increase on pharmaceutical utilization, expenditures, and treatment continuation.
Motheral BR; Henderson R
Am J Manag Care; 1999 Nov; 5(11):1383-94. PubMed ID: 10662412
[TBL] [Abstract][Full Text] [Related]
3. Prescription drug trend begins showing modest slowdown.
Capitation Rates Data; 2002 Jul; 7(7):76-80. PubMed ID: 12164063
[No Abstract] [Full Text] [Related]
4. By the Numbers. Prescription drugs and supplies.
Mod Healthc; 2001 Dec; 31(52 Suppl):30. PubMed ID: 11808395
[No Abstract] [Full Text] [Related]
5. The effect of insurance type on prescription drug use and expenditures among elderly Medicare beneficiaries.
Saleh SS; Weller W; Hannan E
J Health Hum Serv Adm; 2007; 30(1):50-74. PubMed ID: 17557696
[TBL] [Abstract][Full Text] [Related]
6. Gender differences in drug use and expenditures in a privately insured population of older adults.
Correa-de-Araujo R; Miller GE; Banthin JS; Trinh Y
J Womens Health (Larchmt); 2005; 14(1):73-81. PubMed ID: 15692281
[TBL] [Abstract][Full Text] [Related]
7. Current trends in pharmacy benefit management.
Sweet B
Am J Manag Care; 2002 Nov; Suppl():5-8. PubMed ID: 12463412
[No Abstract] [Full Text] [Related]
8. Patterns and predictors of generic narrow therapeutic index drug use among older adults.
Gagne JJ; Polinski JM; Kesselheim AS; Choudhry NK; Hutchins D; Matlin OS; Tong A; Shrank WH
J Am Geriatr Soc; 2013 Sep; 61(9):1586-91. PubMed ID: 24001285
[TBL] [Abstract][Full Text] [Related]
9. Controlling prescription drug expenditures: a report of success.
Miller DP; Furberg CD; Small RH; Millman FM; Ambrosius WT; Harshbarger JS; Ohl CA
Am J Manag Care; 2007 Aug; 13(8):473-80. PubMed ID: 17685828
[TBL] [Abstract][Full Text] [Related]
10. Healthcare utilization and costs of patients with rosacea in an insured population.
Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
[TBL] [Abstract][Full Text] [Related]
11. Seniors' prescription drug cost inflation and cost containment: evidence from British Columbia.
Morgan SG; Agnew JD; Barer ML
Health Policy; 2004 Jun; 68(3):299-307. PubMed ID: 15113641
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical management strategies of industrialized countries.
Brier KL
Formulary; 1995 Oct; 30(10):606-10, 614. PubMed ID: 10151724
[TBL] [Abstract][Full Text] [Related]
13. Relationship between generic and preferred-brand prescription copayment differentials and generic fill rate.
Mager DE; Cox ER
Am J Manag Care; 2007 Jun; 13(6 Pt 2):347-52. PubMed ID: 17567235
[TBL] [Abstract][Full Text] [Related]
14. Datawatch: Update on Rx drug spending.
Bus Health; 2001 Sep; 19(8):48. PubMed ID: 11665673
[No Abstract] [Full Text] [Related]
15. Nondialysis (home) medication utilization and cost in diabetic and nondiabetic hemodialysis patients.
Manley HJ; Cannella CA
Nephrol News Issues; 2005 Jan; 19(2):27-8, 33-4, 36-8. PubMed ID: 15717572
[TBL] [Abstract][Full Text] [Related]
16. Utilization of generics: a managed care failure?
Epstein D
Manag Care; 1997 May; 6(5):85-7. PubMed ID: 10168639
[No Abstract] [Full Text] [Related]
17. Drugmakers exit the comfort zone.
Singer ID
State Health Care Am; 2001; ():24-6. PubMed ID: 11521318
[No Abstract] [Full Text] [Related]
18. [Reimbursement of drug expenses--unseen problem, increasing threats].
Lukawiecki K
Kardiol Pol; 2006 Jul; 64(7):767-9; discussion 770. PubMed ID: 16886139
[No Abstract] [Full Text] [Related]
19. Cost and use management in prescription drug benefits.
Curtiss FR; Tichon MJ
GHAA J; 1988; 9(1):97-104. PubMed ID: 10290681
[No Abstract] [Full Text] [Related]
20. Chronic conditions and disabilities: trends and issues for private drug plans.
Boccuti C; Moon M; Dowling K
Policy Brief Commonw Fund; 2003 Oct; (680):1-10. PubMed ID: 14562797
[No Abstract] [Full Text] [Related]
[Next] [New Search]
